Skip to search.
 TSX Up 0.41% TSX Ventures Up 1.27%

Nuvo Research, Inc. (NRI.TO)

-Toronto
6.10 Down 0.08(1.29%) 12:22PM EDT
Prev Close:6.18
Open:6.22
Bid:6.11
Ask:6.14
1y Target Est:N/A
Beta:-0.393214
Earnings Date:May 10 - May 16 (Est.)
Day's Range:6.05 - 6.22
52wk Range:3.20 - 6.25
Volume:3,175
Avg Vol (3m):26,198
Market Cap:70.07M
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):6.42
P/S (ttm):3.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :1.05
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nuvo Research Inc. operates as a life sciences company. The company operates through two segments, Nuvo Pharma and Crescita. It offers Pennsaid, a topical non-steroidal anti-inflammatory drug that is used to treat the signs and symptoms of osteoar... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback